My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Codex DNA (DNAY)
NASDAQ:DNAY
DNAYCodex DNA
$10.49
-$0.7 (-6.26%)

Codex DNA Stock Analysis & Ratings

Codex DNA Stock Analysis Overview

Smart Score
7
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Codex DNA stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

DNAY

DNAY Stock Stats

Previous Close$11.19
Open$11.32
Bid10.49 x 200
Ask0 x 0
Today’s Range$10.37 - $11.6
52-Week Range$9.53 - $25.70
Volume70.41K
Average Volume151.85K
Market Cap$307.27M
Beta16.61
P/E Ratio-3.9
EPS-2.84
Earnings DateAug 10, 2021

Company Description

Codex DNA

Codex DNA Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide.
Sector
Services
Industry
Medical Devices & Instruments
CEO
Todd R. Nelson
Employees
108
ISIN
US1920031010
Address
9535 Waples Street, San Diego, CA, 92121-2993, US

Financials


P/E Ratio Range

Currently, no data available
Please return soon. This page is being updated.
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

DNAY FAQ

What was Codex DNA’s price range in the past 12 months?
Codex DNA lowest stock price was $9.53 and its highest was $25.70 in the past 12 months.
    What is Codex DNA’s market cap?
    Codex DNA’s market cap is $307.27M.
      What is Codex DNA’s price target?
      The average price target for Codex DNA is $26.50. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $30.00 ,the lowest forecast is $23.00. The average price target represents 152.62% Increase from the current price of $10.49.
        What do analysts say about Codex DNA?
        Codex DNA’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
          When is Codex DNA’s upcoming earnings report date?
          Codex DNA’s upcoming earnings report date is Aug 10, 2021 which is 2 months ago.
            How were Codex DNA’s earnings last quarter?
            Currently, no data Available
            Is Codex DNA overvalued?
            According to Wall Street analysts Codex DNA’s price is currently Undervalued.
              Does Codex DNA pay dividends?
              Codex DNA does not currently pay dividends.
              What is Codex DNA’s EPS estimate?
              Codex DNA’s EPS estimate is -$1.06.
                How many shares outstanding does Codex DNA have?
                Codex DNA has 29,290,000 shares outstanding.
                  What happened to Codex DNA’s price movement after its last earnings report?
                  Currently, no data Available
                  Which hedge fund is a major shareholder of Codex DNA?
                  Among the largest hedge funds holding Codex DNA’s share is Perceptive Advisors LLC. It holds Codex DNA’s shares valued at 9M.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis